Back
ESC Professional Premium Access

One-year outcomes of patients with hypertrophic cardiomyopathy according to levels of inflammatory biomarkers

Session: Hypertrophic cardiomyopathy: risk prediction and outcomes
Topic: Hypertrophic Cardiomyopathy
Speaker: Doctor M. Golino (Jacksonville, US)
Event: ESC Congress 2024

Congress Presentation

Add to my library

Like

About the speaker

Doctor Michele Golino

University of Florida College of Medicine – Jacksonville, Jacksonville (United States of America)
1 presentation
0 follower

6 more presentations in this session

CMR phenotypes and clinical outcomes in NYHA class I versus II-IV hypertrophic cardiomyopathy: identifying high-risk asymptomatic patients

Speaker: Doctor D. Labib (Calgary, CA)

Access
Abstract
Slides
Video
Like
Thumbnail

High-intensity exercise-related sudden cardiac death in hypertrophy cardiomyopathy

Speaker: Doctor H. Lee (Seoul, KR)

Access
Abstract
Slides
Video
Like
Thumbnail

The relationship between serum lumican levels and myocardial fibrosis in patients with hypertrophic cardiomyopathy

Speaker: Doctor E. Hancioglu (Hatay, TR)

Access
Abstract
Slides
Video
Like
Thumbnail

Invasive quantitative assessment of coronary microvascular dysfunction in patients with hypertrophic cardiomyopathy

Speaker: Doctor M. Marques Antunes (Lisboa, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

Prolonged ventricular activation time as a novel biomarker identifying burn-out phase of hypertrophic cardiomyopathy

Speaker: Doctor K. Fragkiadakis (Heraklion, GR)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Hypertrophic cardiomyopathy: risk prediction and outcomes

Speakers: Doctor M. Golino, Doctor D. Labib, Doctor H. Lee, Doctor E. Hancioglu, Doctor M. Marques Antunes...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources